Dinucleotide microsatellite repeats are essential for the diagnosis of microsatellite instability in

来源 :World Journal of Gastroenterology | 被引量 : 0次 | 上传用户:one_tester
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM: The molecular diagnosis of microsatellite instability (MSI) in colorectal cancer (CRC) is based on the analysis of five microsatellite markers. Among them, the two mononu-cleotide microsatellite repeats are considered more informative for this analysis than the three dinucleotide ones. The aim of this study is to establish the most relevant markers for MSI analysis in colorectal cancers from Asian patients. METHODS: The MSI analysis of 143 CRC cases in a routine molecular diagnostic laboratory was reviewed. Analysis by fluorescence-based PCR of the five recommended microsatellites was performed, followed by data interpretation according to internationally accepted guidelines. The results were analyzed to address (1) the rate of success in the analysis of histopathological samples not specifically prepared for molecular analysis; (2) the relative importance of individual markers in the diagnosis of high-MSI (H-MSI). RESULTS: MSI analysis was unsuccessful in 34 cases (24%), but for tissues archived in recent years the unsuccessful rate was 5%. We found the D2S123 marker the most vulnerable to inadequate tissue preservation, failing to amplify in 58 instances. Approximately 30% (32/109) of the cases were H-MSI, while 7/109 (6%) were low-MSI. A detailed analysis of the H-MSI cases revealed that the dinucleotide repeats (and D5S346 in particular) were more relevant than the mononucleotide repeats in assigning the correct MSI status. CONCLUSION: The analysis of dinucleotide repeats is essential for the establishment of MSI status in Asian CRC patients. AIM: The molecular diagnosis of microsatellite instability (MSI) in colorectal cancer (CRC) is based on the analysis of five microsatellite markers. Among them, the two mononu-cleotide microsatellite repeats are considered more informative for this analysis than the three dinucleotide ones. The aim of this study is to establish the most relevant markers for MSI analysis in colorectal cancers from Asian patients. METHODS: The MSI analysis of 143 CRC cases in a routine molecular diagnostic laboratory was reviewed. Analysis by fluorescence-based PCR of the five recommended The results were analyzed to address (1) the rate of success in the analysis of histopathological samples not specifically prepared for molecular analysis; (2) the relative importance of individual markers in the diagnosis of high-MSI (H-MSI). RESULTS: MSI analysis was unsuccessful in 34 cases (24%), but for tissues archived in recent years the unsuccessful rate was 5%. We found the D2S123 marker the most vulnerable to inadequate tissue preservation, failing to amplify in 58 instances. Approximately 30% (32/109) of the cases were H-MSI, while 7 A detailed analysis of the H-MSI cases revealed that the dinucleotide repeats (and D5S346 in particular) were more relevant than the mononuclear repeats in assigning the correct MSI status. CONCLUSION: The analysis of dinucleotide repeats is essential for the establishment of MSI status in Asian CRC patients.
其他文献
目的:探讨临床收治小儿抽动障碍病患采用氟哌啶醇与托吡酯联合方案治疗的效果与安全性.方法:所取124例研究对象均系我院2017年1月~2018年10月所收治小儿抽动障碍病患,予以随机
目的:探究认知行为团体矫正对未成年暴力犯暴力风险水平的影响.方法:在某未成年监狱中随机选取中高风险的未成年暴力犯50名,其中24人进入矫正组,26人作为对照组.对矫正组进行
期刊
患者男,24岁.因咽痛2 d,来门诊就诊.查体:T 37.0℃,P 76次·min-1,R 18次·min-1,BP 110/70mmHg(1 mmHg=0.133 kPa),咽部发红、肿痛,其余均(-).血常规:WBC 1.0×10 9·L-1,RB
目的:分析剖宫产患者术后应用疼痛护理干预的效果.方法:2017年6月至2018年8月在我院接受剖宫产的产妇中随机选取88例,通过随机抽签法将入选产妇分为研究组(n=44)以及参考组(n
目的探讨慢性肾功能衰竭患者桡动脉的病理特点,并分析其相关性危险因素。方法收集2012年1月至2016年1月梧州市工人医院肾内科确诊为慢性肾功能衰竭的40例患者,根据发病原因分为糖尿病组、慢性肾炎组、肾结石组以及高血压组,每组10例。采用χ2检验及回归性分析方法分析慢性肾功能衰竭患者的原发病临床特点及桡动脉病理表现,并探讨桡动脉内膜增厚、血管壁变性等相关危险因素,观察4组患者内瘘手术后的血管通畅情况
数码显微互动实验室是一种在医学形态学实验课上教学过程中优势较为明显的一种方式,在一个方面上它消除了师生之间在显微图像上的一些沟通障碍,可以充分的实现师生之间的互动
目的:分析缬沙坦联合阿托伐他汀治疗慢性肾炎的效果.方法:研究对象为我院收治的慢性肾炎患者68例,选取时间为2018年6月~2019年3月间,按照随机数字表法进行分组对比,一组为采取
目的:探讨解毒通络浸膏对实验性糖尿病大鼠心肌的保护作用。方法:38只Wistar大鼠分为正常组8只、糖尿病心肌病(DCM)模型组及治疗组。DCM模型将造模的30只大鼠随机分为DCM模型组、